Article
Analysis of clinical characteristics and treatment efficacy in two pediatric cases of ANKRD26-related thrombocytopenia.
Platelets - 1 Dec 2023
Pang Congfei, Wu Xiaomei, Nikuze Lauriane, Wei Hongying
Abstract excerpt
ANKRD26-related thrombocytopenia (ANKRD26-RT or THC2, MIM 188 000), an autosomal dominant thrombocytopenia, is unresponsive to immunosuppressive therapy and susceptible to hematological malignancies. A large number of pediatric patients are diagnosed with immune thrombocytopenia (ITP) every year; however, thrombocytopenia of genetic origin is often missed. Extensive characterization of ANKRD26-RT will help...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
